ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm receives $1.34 million R&D tax incentive rebate
Published: 22/03/17, 09:25am (AEST)•1 pages